Simultaneous endometrioid ovarian and uterine carcinoma diagnosed after an in vitro fertilization procedure- Case report and review of the literature

Background: The presence of simultaneous carcinomas involving both the ovary and uterus is relatively uncommon, while the possible link between fertility drugs and carcinogenesis still remains controversial.

Case: The case of a 40-year-old patient with simultaneous aggressive endometrioid carcinoma of the ovary and uterus a few months after the sixth attempt of in vitro fertilization is presented. The patient had de novo lung disease at surgery and diffuse metastatic spread to adjacent bone, subcutaneous tissue and the central nervous system (CNS) soon after a spectacular response to the primary paclitaxel/carboplatinum chemotherapy and while on maintenance and second-line chemotherapy, respectively.

Conclusion: The fulminating course of our patient might in part be attributed to the existence of advanced disease at presentation. Definite conclusions about the possible association with the previously performed assisted reproduction cannot be drawn but close clinical surveillance of such patients before, during and after infertility treatment is strongly warranted.

Endometrioid carcinoma; Ovarian cancer; Uterine cancer; In vitro fertilization

[1] Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A.. Buller R.E.: "Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study". Gynecol. Oncol., 2001, 83, 355.

[2] Venn A., Healy D., McLachlan R.: "Cancer risks associated with the diagnosis of infertility". Best. P ract. Res. Clin. Obstet Gynaecol., 2003, 17, 343.

[3] Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J.E.. Westhoff C.L.: "Ovarian cancer risk after the use of ovulation-stimulating drugs". Obstet. Gynecol., 2004, 103, 1194.

[4] Horiuchi A., Itoh K., Shimizu M., Nakai I., Yamazaki T., Kimura K. et al.: "Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach". Gynecol Oneal., 2003, 88, 309.

[5] Ness R.B.: "Endometriosis and ovarian cancer: thoughts on shared pathophysiology". Arn. J. Obstet. Gynecol., 2003, 189, 280.

[6] Kline R.C., Wharton J.T., Atkinson E.N., Burke T.W., Gershenson D.M., Edwards C.L.: "Endometrioid carcinoma of the ovary: retrospective review of 145 cases". Gynecol. Oneal., 1990, 39, 337.

[7] Falkenberry S.S., Steinhoff M.M., Gordinier M., Rappoport S., Gajewski W., Granai C.O.: "Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases". J. Reprod. Med., 1996, 41, 713.

[8] Soliman P.T., Slomovitz B.M., Broaddus R.R., Sun C.C., Oh J.C., Eifel P.J. et al.: "Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases". Gynecol. Oncol., 2004, 94, 456.

[9] Ayhan A., Guvenal T., Coskun F., Basaran M., Salman M.C.: "Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries". Eur. J. Gynaecol. Oncol., 2003, 24, 171.

[10] Ricci R., Komminoth P., Bannwart F., Torhorst J., Wight E., Heitz P.U., Caduff R.F.: "PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus". Diagn. Mal. Pathol., 2003, 12, 71.

[11] Gotoh T., Hayashi N., Takeda S., ltoyama S., Takano M., Kikuchi Y.: "Synchronous mucinous adenocarcinoma of the endometrium and mucinous cystadenoma of bilateral ovaries presenting during fertility therapy". Int. J. Gynecol. Cancer, 2004, 14, 169.

[12] Whittemore A.S., Harris R., Itnyre J.: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group". Arn. J. Epiderniol., 1992, 136, 1212.

[13] Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., Self S.G "Ovarian tumors in a cohort of infertile women". N. Engl. J. Med., 1994, 331,771.

[14] Kashyap S., Moher D., Fung M.F.K., Rosenwaks Z.: "Assisted reproductive technology and the incidence of ovarian cancer: A meta-analysis". Obstet. Gynecol., 2004, 103, 785.

[15] Dor J., Lerner-Geva L., Rabinovici J., Chetrit A., Levran D., Lunenfeld B. et al.: "Cancer incidence in a cohort of infertile women who underwent in vitro fertilization". Fertil. Steril., 2002, 77, 324.

[16] Venn A., Watson L ., Bruinsma F., Giles G., Healy D.: "Risk of cancer after use of fertility drugs with in-vitro fertilization". Lancet, 1999, 354, 1586.